| 标题 |
First‐in‐human study of HDM1002 , a GLP ‐1 receptor agonist: Safety, tolerability, pharmacokinetics and pharmacodynamics of escalating single oral doses in healthy volunteers |
| 网址 | |
| DOI | |
| 其它 |
期刊:Diabetes, Obesity and Metabolism 作者:Junliang Pu; Yurui Huang; Lei Wan; Mingxue Zhu; Huili Wei; et al 出版日期:2025-07-15 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)